Moderated Posters Session 1

3:05 PM - 3:50 PM

Development and validation of a symptom assessment tool for postmicturition dribble: A prospective, multicenter, observational study in Korea

Dr Hyun Cheol Jeong (1), Dr Kyung Tae Ko (1), Dr Dae yul Yang (1), Dr Won Ki Lee (2), Dr Sung Tae Cho (3), Dr Cheol Young Oh (4), Dr Seong Ho Lee (5)

(1) Kangdong Sacred Heart Hospital, , South Korea, (2) Chuncheon Sacred Heart Hospital, , South Korea, ( 3) Kangnam Sacred Heart Hospital, , South Korea, (4) Hallym Sacred Heart Hospital, , South Korea, (5) Dongtan Sacred Heart Hospital, , South Korea


Postmicturition dribble (PMD) is a very common symptom in males with lower urinary tract symptoms (LUTS) worldwide, but there is no adequate questionnaire to assess it. Therefore, we developed a questionnaire named the Hallym Post Micturition Dribble Questionnaire (HPMDQ) to assess PMD, and the aim of this study is to validate it.


A series of consecutive male patients newly diagnosed with LUTS and over 40 years of age who visited any of 5 medical institutions were included. LUTS were assessed in all patients using the International Prostate Symptom Score (IPSS), and PMD was assessed using the HPMDQ.


In total, 2134 male patients aged 40 to 91 years were included in this study. Of these patients, 1088 (51.0%) reported PMD. In the PMD group, the mean values for HPMDQ-Q1, HPMDQ-Q2, HPMDQ-Q3 and HPMDQ total score were 1.39, 1.10, 1.76 and 4.25, respectively. In the non-PMD group, the mean values of these scores were 0, 0.18, 1.52 and 1.58, respectively. The difference in HPMDQ scores between the 2 groups was statistically significant. PMD was significantly associated with the voiding symptoms of LUTS, prostate size and postvoid residual but not with storage symptoms.


The HPMDQ, which consists of 5 questions (frequency, severity, bother, quality of life and response to treatment for PMD), was developed, and its use for assessing PMD is validated in this study. It may be a useful tool for further research and in clinical practice for PMD.